Status:
ENROLLING_BY_INVITATION
The Effect of Partner-Assisted Rebozo Application in the Intrapartum Period on Birth Fear, Pain and Satisfaction
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Rebozo at Birth
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The World Health Organization (WHO) recommends the use of non-pharmacological methods for the relief of labor pain. The use of non-pharmacological methods in pain management helps women see their labo...
Detailed Description
Childbirth is a challenging and life-changing experience for women that has emotional and physical effects. Every woman wants to remember her childbirth as a positive process, but the pain and sufferi...
Eligibility Criteria
Inclusion
- Being literate,
- Knowing Turkish,
- Being over 18 years of age,
- Being primiparous,
- Having a single fetus and cephalic presentation,
- Being at term (37-42 weeks),
- Not having risk factors during pregnancy (Preeclampsia, premature rupture of membranes, oligohydramnios and polyhydramnios, gestational diabetes, placental anomalies, intrauterine growth retardation, intrauterine dead fetus, fetal distress, macrosomic babies, etc.),
- Being in the active phase of the first stage of labor,
- Those who agree to participate in the research,
- The spouse also agrees to participate in the research.
Exclusion
- Being multiparous,
- Having multiple pregnancies,
- Women with any chronic disease,
- Women with a diagnosed psychiatric disease,
- Pregnant women with spine and bone structure problems.
Key Trial Info
Start Date :
July 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06887608
Start Date
July 22 2025
End Date
September 15 2026
Last Update
July 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Training and Research Hospital
Zeytinburnu, Istanbul, Turkey (Türkiye), 34020